Uri Ladabaum

11.3k total citations · 5 hit papers
192 papers, 6.8k citations indexed

About

Uri Ladabaum is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Uri Ladabaum has authored 192 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Oncology, 73 papers in Pulmonary and Respiratory Medicine and 64 papers in Pathology and Forensic Medicine. Recurrent topics in Uri Ladabaum's work include Colorectal Cancer Screening and Detection (112 papers), Gastric Cancer Management and Outcomes (69 papers) and Genetic factors in colorectal cancer (62 papers). Uri Ladabaum is often cited by papers focused on Colorectal Cancer Screening and Detection (112 papers), Gastric Cancer Management and Outcomes (69 papers) and Genetic factors in colorectal cancer (62 papers). Uri Ladabaum collaborates with scholars based in United States, Netherlands and Canada. Uri Ladabaum's co-authors include Ajitha Mannalithara, Robert E. Schoen, Charles J. Kahi, A. Mark Fendrick, Jason A. Dominitz, Scarlett Lin Gomez, Parvathi A. Myer, Gurkirpal Singh, Robert W. Haile and Alison J. Canchola and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Uri Ladabaum

180 papers receiving 6.7k citations

Hit Papers

The American Society for Gastrointestinal Endoscopy PIVI ... 2011 2026 2016 2021 2011 2019 2017 2022 2024 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on real-time endoscopic assessment of the histology of diminutive colorectal polyps
    2011 421 citations Uri Ladabaum, David A. Lieberman et al. Gastrointestinal Endoscopy profile →
  2. Strategies for Colorectal Cancer Screening
    2019 414 citations Uri Ladabaum, Jason A. Dominitz et al. Gastroenterology profile →
  3. Racial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood Characteristics
    2017 381 citations Uri Ladabaum et al. profile →
  4. Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer
    2022 154 citations Uri Ladabaum, James M. Ford et al. profile →
  5. Comparative Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With Blood-Based Biomarkers (Liquid Biopsy) vs Fecal Tests or Colonoscopy
    2024 45 citations Uri Ladabaum, Ajitha Mannalithara et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Uri Ladabaum United States 46 3.9k 2.2k 1.8k 1.8k 813 192 6.8k
Geir Hoff Norway 44 4.2k 1.1× 2.7k 1.2× 1.6k 0.9× 1.6k 0.9× 248 0.3× 197 5.9k
Douglas J. Robertson United States 48 7.8k 2.0× 5.6k 2.5× 3.2k 1.8× 2.7k 1.5× 594 0.7× 154 9.8k
Byung Ho Son South Korea 34 1.9k 0.5× 1.2k 0.5× 786 0.4× 1.1k 0.6× 280 0.3× 262 4.6k
Kohei Akazawa Japan 41 1.5k 0.4× 2.3k 1.0× 430 0.2× 1.9k 1.1× 663 0.8× 202 6.1k
Laurel A. Habel United States 47 3.7k 0.9× 1.8k 0.8× 658 0.4× 2.0k 1.1× 417 0.5× 200 9.9k
Kent‐Man Chu Hong Kong 48 1.3k 0.3× 2.6k 1.2× 628 0.4× 3.8k 2.2× 850 1.0× 148 8.1k
Janet L. Stanford United States 59 2.9k 0.7× 6.1k 2.7× 840 0.5× 2.9k 1.7× 223 0.3× 194 12.1k
Claudio Luchini Italy 40 2.8k 0.7× 1.2k 0.5× 758 0.4× 1.7k 0.9× 148 0.2× 206 7.3k
Edoardo Botteri Italy 45 3.6k 0.9× 1.4k 0.6× 2.1k 1.2× 1.9k 1.1× 85 0.1× 181 8.2k
Patrick J. Flynn United States 51 6.9k 1.8× 2.6k 1.2× 2.2k 1.2× 1.4k 0.8× 85 0.1× 145 11.1k

Countries citing papers authored by Uri Ladabaum

Since Specialization
Citations

This map shows the geographic impact of Uri Ladabaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uri Ladabaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uri Ladabaum more than expected).

Fields of papers citing papers by Uri Ladabaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uri Ladabaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uri Ladabaum. The network helps show where Uri Ladabaum may publish in the future.

Co-authorship network of co-authors of Uri Ladabaum

This figure shows the co-authorship network connecting the top 25 collaborators of Uri Ladabaum. A scholar is included among the top collaborators of Uri Ladabaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uri Ladabaum. Uri Ladabaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ladabaum, Uri. (2025). All Aboard the All-Exam Adenoma Detection Rate. The American Journal of Gastroenterology. 121(2). 300–301.
2.
O’Mahony, James F., Dianqin Sun, Robert J. Huang, et al.. (2025). The Optimal Age of Helicobacter pylori Screen‐and‐Treat for Gastric Cancer Prevention in the United States. Helicobacter. 30(3). e70039–e70039. 2 indexed citations
3.
Half, Elizabeth, Zohar Levi, Ajitha Mannalithara, et al.. (2024). Colorectal cancer screening at age 45 years in Israel: Cost‐effectiveness and global implications. Cancer. 130(6). 901–912. 2 indexed citations
4.
Ladabaum, Uri, Ajitha Mannalithara, Yingjie Weng, et al.. (2024). Comparative Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With Blood-Based Biomarkers (Liquid Biopsy) vs Fecal Tests or Colonoscopy. Gastroenterology. 167(2). 378–391. 45 indexed citations breakdown →
5.
Ladabaum, Uri, Ajitha Mannalithara, Yingjie Weng, et al.. (2024). Sa1146 COMPARATIVE EFFECTIVENESS AND COST-EFFECTIVENESS OF COLORECTAL CANCER (CRC) SCREENING WITH BLOOD-BASED BIOMARKERS (LIQUID BIOPSY) VS. FECAL TESTS OR COLONOSCOPY. Gastroenterology. 166(5). S–359. 1 indexed citations
6.
Huang, Robert J., Margaret Zhou, John D. Murphy, et al.. (2024). Prevalence of Gastric Precursor Lesions in Countries With Differential Gastric Cancer Burden: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 22(8). 1605–1617.e46. 18 indexed citations
7.
Huang, Robert J., Margaret Zhou, John D. Murphy, et al.. (2024). Global Progression Rates of Precursor Lesions for Gastric Cancer: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology. 23(9). 1514–1524.e13. 12 indexed citations
8.
Culver, Julie O., Yuxi Liu, Charité Ricker, et al.. (2023). Clinical implications of conflicting variant interpretations in the cancer genetics clinic. Genetics in Medicine. 25(7). 100837–100837. 3 indexed citations
9.
Ladabaum, Uri, John Shepard, Yingjie Weng, et al.. (2023). 745 COMPUTER-AIDED DETECTION OF POLYPS DOES NOT IMPROVE COLONOSCOPIST PERFORMANCE IN A PRAGMATIC IMPLEMENTATION TRIAL. Gastroenterology. 164(6). S–152. 1 indexed citations
10.
Grimes, Barbara, et al.. (2021). Increased Colorectal Cancer Screening Sustained with Mailed Fecal Immunochemical Test Outreach. Clinical Gastroenterology and Hepatology. 20(6). 1326–1333.e4. 10 indexed citations
11.
Ladabaum, Uri, et al.. (2021). Colorectal Cancer Incidence After Colonoscopy at Ages 45–49 or 50–54 Years. Gastroenterology. 160(6). 2018–2028.e13. 20 indexed citations
12.
Melson, Joshua, Thomas F. Imperiale, Steven H. Itzkowitz, et al.. (2020). AGA White Paper: Roadmap for the Future of Colorectal Cancer Screening in the United States. Clinical Gastroenterology and Hepatology. 18(12). 2667–2678.e2. 24 indexed citations
13.
Ladabaum, Uri, Ateev Mehrotra, Shahrzad Tehranian, et al.. (2018). Incidence of interval colorectal cancer attributable to an endoscopist in clinical practice. Gastrointestinal Endoscopy. 88(4). 705–711.e1. 16 indexed citations
14.
Chen, Frank W., Vandana Sundaram, Thomas A. Chew, & Uri Ladabaum. (2016). Advanced-Stage Colorectal Cancer in Persons Younger Than 50 Years Not Associated With Longer Duration of Symptoms or Time to Diagnosis. Clinical Gastroenterology and Hepatology. 15(5). 728–737.e3. 201 indexed citations
15.
Gupta, Samir, Elizabeth T. Jacobs, John A. Baron, et al.. (2015). Risk stratification of individuals with low-risk colorectal adenomas using clinical characteristics: a pooled analysis. Gut. 66(3). 446–453. 32 indexed citations
16.
Ladabaum, Uri, John M. Allen, Michael Wandell, & Scott D. Ramsey. (2013). Colorectal Cancer Screening with Blood-Based Biomarkers: Cost-Effectiveness of Methylated Septin 9 DNA versus Current Strategies. Cancer Epidemiology Biomarkers & Prevention. 22(9). 1567–1576. 66 indexed citations
17.
Elkin, Elena B., Deborah A. Marshall, Nathalie A. Kulin, et al.. (2011). Economic evaluation of targeted cancer interventions: Critical review and recommendations. Genetics in Medicine. 13(10). 853–860. 19 indexed citations
18.
Wilcox, C. Mel, Jeroan J. Allison, Keith H. Benzuly, et al.. (2006). Consensus Development Conference on the Use of Nonsteroidal Anti-Inflammatory Agents, Including Cyclooxygenase-2 Enzyme Inhibitors and Aspirin. Clinical Gastroenterology and Hepatology. 4(9). 1082–1089.e4. 66 indexed citations
19.
Aisenberg, James, Joel V. Brill, Uri Ladabaum, & Lawrence B. Cohen. (2005). Sedation for Gastrointestinal Endoscopy: New Practices, New Economics. The American Journal of Gastroenterology. 100(5). 996–1000. 78 indexed citations
20.
Ladabaum, Uri & David V. Glidden. (2002). Effect of the selective serotonin reuptake inhibitor sertraline on gastric sensitivity and compliance in healthy humans1. Neurogastroenterology & Motility. 14(4). 395–402. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geir Hoff Breakdown of academic impact, for papers by Douglas J. Robertson Breakdown of academic impact, for papers by Byung Ho Son Breakdown of academic impact, for papers by Kohei Akazawa Breakdown of academic impact, for papers by Laurel A. Habel Breakdown of academic impact, for papers by Kent‐Man Chu Breakdown of academic impact, for papers by Janet L. Stanford Breakdown of academic impact, for papers by Claudio Luchini Breakdown of academic impact, for papers by Edoardo Botteri Breakdown of academic impact, for papers by Patrick J. Flynn
Rankless by CCL
2026